Pub Date : 2026-03-20DOI: 10.1007/s00277-026-06917-1
Yue Yu, Siqin Liao, Hongda Su, Zhiyong Li, Meijuan Zheng, Cong Chen, Ensheng Xue, Zhenhu Lin
{"title":"Development and validation of the ultrasound-based radiomics and deep learning prognostic models for diffuse large B-cell lymphoma.","authors":"Yue Yu, Siqin Liao, Hongda Su, Zhiyong Li, Meijuan Zheng, Cong Chen, Ensheng Xue, Zhenhu Lin","doi":"10.1007/s00277-026-06917-1","DOIUrl":"10.1007/s00277-026-06917-1","url":null,"abstract":"","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":"105 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002698/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147484319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-19DOI: 10.1007/s00277-026-06941-1
Akmaral Jazyltayeva, Nazarii Shokun, Ayazhan Umutbayeva, Luana Conte, Raigul Ramazanova, Vadim Kemaikin, Azat Karabekov, Aidana Shalabay, Aigerim Koshkarbayeva, Nurbergen Kemelbekov, Madina Zhumabay, Fariza Shokubayeva, Yana Stepanihyna, Massimo Federico, Saule Gabbasova
{"title":"Treatment of Burkitt lymphoma in real-world setting: findings on 104 consecutive cases diagnosed and treated in Kazakhstan over the last decade.","authors":"Akmaral Jazyltayeva, Nazarii Shokun, Ayazhan Umutbayeva, Luana Conte, Raigul Ramazanova, Vadim Kemaikin, Azat Karabekov, Aidana Shalabay, Aigerim Koshkarbayeva, Nurbergen Kemelbekov, Madina Zhumabay, Fariza Shokubayeva, Yana Stepanihyna, Massimo Federico, Saule Gabbasova","doi":"10.1007/s00277-026-06941-1","DOIUrl":"10.1007/s00277-026-06941-1","url":null,"abstract":"","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":"105 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12999861/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147479547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-19DOI: 10.1007/s00277-026-06832-5
Turgut Gürer, Ulgar Boran Günay, Berkay Kılıç, Ayşegül Akkan Suzan, Duygu Seyhan Erdoğan, Deniz Özmen, Tuğrul Elverdi, Ayşe Salihoğlu, Ayşegül Gündüz, Muhlis Cem Ar, Zafer Başlar, Ahmet Emre Eşkazan
{"title":"Restless legs syndrome in chronic myeloid leukemia: an overlooked condition with a significant impact on health-related quality of life.","authors":"Turgut Gürer, Ulgar Boran Günay, Berkay Kılıç, Ayşegül Akkan Suzan, Duygu Seyhan Erdoğan, Deniz Özmen, Tuğrul Elverdi, Ayşe Salihoğlu, Ayşegül Gündüz, Muhlis Cem Ar, Zafer Başlar, Ahmet Emre Eşkazan","doi":"10.1007/s00277-026-06832-5","DOIUrl":"10.1007/s00277-026-06832-5","url":null,"abstract":"","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":"105 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12999824/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147479481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-18DOI: 10.1007/s00277-026-06911-7
Claudia Giordano, M Picardi, F Esposito, A Vincenzi, N Pugliese, A Lombardi, F Trastulli, R Secchi, M Postorino, M Annunziata, A Venditti, F Pane
{"title":"Lipegfilgrastim for primary prophylaxis of febrile neutropenia in patients treated for advanced-stage classical hodgkin lymphoma: successful outcomes from a multicenter cohort study.","authors":"Claudia Giordano, M Picardi, F Esposito, A Vincenzi, N Pugliese, A Lombardi, F Trastulli, R Secchi, M Postorino, M Annunziata, A Venditti, F Pane","doi":"10.1007/s00277-026-06911-7","DOIUrl":"10.1007/s00277-026-06911-7","url":null,"abstract":"","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":"105 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12999601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147479557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-18DOI: 10.1007/s00277-026-06869-6
Zhengwei Tan, Yuechao Zhao, Huijin Hu, Qinghong Yu, Yu Zhang, Tonglin Hu, Dijiong Wu, Baodong Ye, Wenbin Liu
{"title":"Comparison of clinical outcomes between early and delayed allogeneic hematopoietic stem cell transplantation for severe aplastic anemia: a single-center retrospective study.","authors":"Zhengwei Tan, Yuechao Zhao, Huijin Hu, Qinghong Yu, Yu Zhang, Tonglin Hu, Dijiong Wu, Baodong Ye, Wenbin Liu","doi":"10.1007/s00277-026-06869-6","DOIUrl":"10.1007/s00277-026-06869-6","url":null,"abstract":"","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":"105 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12995939/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147472523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-18DOI: 10.1007/s00277-026-06923-3
Sen-Xin Wang, Tao Luo, Ni Yang, Xun-Ru Liu, Yan-Ping Ma
This project tracks Asia-Pacific multiple myeloma (MM) disease burden from 1990 to 2021. This research predicts incidence and death trends due to aging populations, healthcare resource disparities, gender, regional differences, and health inequities. The 2021 Global Burden of Disease (GBD) database was used to extract Asia-Pacific MM incidence, mortality, and Disability Adjusted Life Year (DALY) by age and sex from 1990 to 2021. Joinpoint regression studied temporal patterns, while APC models deconstructed drivers. The slope inequality index (SII) and concentration index (CI) measured health inequalities, whereas decomposition analysis measured aging, population growth, and epidemiological transition. Predictions using Autoregressive Integrated Moving Average(ARIMA) and Bayesian Age-Period-Cohort(BAPC). Between 1990 and 2021, the worldwide burden of MM grew, particularly in China, where age-standardized incidence reached 918.69%, death 326%, and DALY 622.15%. Approximately 60% of East Asia's increase was due to population aging. Males were more affected than females, with most occurrences occurring in those over 70. Early diagnosis was common in low-income communities. MM prevalence correlated positively with Socio-demographic Index (SDI) except in Japan, where it varied negatively. Disease incidence is predicted to rise in China, while fatality rates should steady. Additionally, male disease burden is expected to continue higher than female disease burden throughout time. MM incidence, mortality, and DALY have increased globally and in the Asia-Pacific area. China's disease burden is male-dominated, age-driven, and positively correlated with SDI. Future incidence rates are predicted to climb, especially among the elderly and males, requiring differentiated prevention and control efforts. Innovative global tactics may come from the Japanese model.
{"title":"Burden of disease for multiple myeloma in China and the Asia-Pacific region, 1990-2021: a systematic analysis of the Global Burden of Disease (GBD) 2021 study.","authors":"Sen-Xin Wang, Tao Luo, Ni Yang, Xun-Ru Liu, Yan-Ping Ma","doi":"10.1007/s00277-026-06923-3","DOIUrl":"10.1007/s00277-026-06923-3","url":null,"abstract":"<p><p>This project tracks Asia-Pacific multiple myeloma (MM) disease burden from 1990 to 2021. This research predicts incidence and death trends due to aging populations, healthcare resource disparities, gender, regional differences, and health inequities. The 2021 Global Burden of Disease (GBD) database was used to extract Asia-Pacific MM incidence, mortality, and Disability Adjusted Life Year (DALY) by age and sex from 1990 to 2021. Joinpoint regression studied temporal patterns, while APC models deconstructed drivers. The slope inequality index (SII) and concentration index (CI) measured health inequalities, whereas decomposition analysis measured aging, population growth, and epidemiological transition. Predictions using Autoregressive Integrated Moving Average(ARIMA) and Bayesian Age-Period-Cohort(BAPC). Between 1990 and 2021, the worldwide burden of MM grew, particularly in China, where age-standardized incidence reached 918.69%, death 326%, and DALY 622.15%. Approximately 60% of East Asia's increase was due to population aging. Males were more affected than females, with most occurrences occurring in those over 70. Early diagnosis was common in low-income communities. MM prevalence correlated positively with Socio-demographic Index (SDI) except in Japan, where it varied negatively. Disease incidence is predicted to rise in China, while fatality rates should steady. Additionally, male disease burden is expected to continue higher than female disease burden throughout time. MM incidence, mortality, and DALY have increased globally and in the Asia-Pacific area. China's disease burden is male-dominated, age-driven, and positively correlated with SDI. Future incidence rates are predicted to climb, especially among the elderly and males, requiring differentiated prevention and control efforts. Innovative global tactics may come from the Japanese model.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":"105 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12996020/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147472467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-17DOI: 10.1007/s00277-026-06930-4
Xia Mao, Kefeng Shen, Jin Wang, Zhiqiong Wang, Qilin Ao, Chunyan Wang, Min Xiao
{"title":"TET2 germline mutation in a patient with sequential lymphoid malignancies: a novel case report.","authors":"Xia Mao, Kefeng Shen, Jin Wang, Zhiqiong Wang, Qilin Ao, Chunyan Wang, Min Xiao","doi":"10.1007/s00277-026-06930-4","DOIUrl":"10.1007/s00277-026-06930-4","url":null,"abstract":"","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":"105 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12995931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147472539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号